stockrowTransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −31.0%
- Free cash flow
- −55.4%
- Total debt
- −89.3%
Quarter to September 2026, against a year earlier
Follow TMDX
Alert me
TransMedics Group, Inc. (TMDX) Free cash flow
TransMedics Group, Inc.'s free cash flow for fiscal 2025 was $133.6M, compared with −$80.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was $44.7M. Over the past ten years it has ranged from −$192.1M (fiscal 2023) to $133.6M (fiscal 2025) — the current reading is the highest in ten years. TransMedics Group, Inc. ranks 31st of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $133.6M | — |
| FY2024 | −$80.9M | — |
| FY2023 | −$192.1M | — |
| FY2022 | −$57.7M | — |
| FY2021 | −$32.4M | — |
| FY2020 | −$30.7M | — |
| FY2019 | −$32.5M | — |
| FY2018 | −$26.4M | — |
| FY2017 | −$23.1M | — |
| FY2016 | −$24.2M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $27.6M | 170.18% |
| Jun 2026 | $10.2M | — |
| Mar 2026 | −$12.1M | — |
| Dec 2025 | $19.0M | (69.33%) |
| 31 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | $97.9M |
| UFPT UFP Technologies, Inc. compare | $61.5M |
| NEOG Neogen Corporation compare | $49.9M |
| TMDX TransMedics Group, Inc. | $44.7M |
| AXGN AxoGen, Inc. compare | $20.0M |
| NVCR NovoCure Limited compare | −$24.6M |
| BFLY Butterfly Network, Inc. compare | −$27.6M |
| ESTA Establishment Labs Holdings Inc. compare | −$41.6M |
| ALMR Alamar Biosciences, Inc. compare | −$110.1M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on TMDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement